Back to search

France· FR:62070450

ZIAGEN 20 mg/ml, solution buvable

A medicinal product containing abacavir (sulfate d'), registered in France by VIIV HEALTHCARE UK (ROYAUME-UNI), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedZIAGEN 20 mg/ml, solution buvableATC—REGISTER NO.FR:62070450PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ABACAVIR (SULFATE D')
Manufacturer
VIIV HEALTHCARE UK (ROYAUME-UNI)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936109056
    1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 240 ml avec seringue(s) doseuse(s) polypropylène polyéthylène
    EUR 75.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Abacavir (sulfate d') in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abacavir (sulfate d') products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Spain · Abacavir Tarbis
  • Finland · Abacavir Accord
  • United Kingdom (Northern Ireland) · Abacavir Milpharm, Abacavir Mylan
  • Iceland · Ziagen
  • Italy · Abacavir Mylan
  • Liechtenstein · Ziagen
  • Netherlands · Abacavir Accord, Abacavir Sandoz
  • Norway · Ziagen
  • Portugal · Abacavir Farmoz, Abacavir Generis
  • Romania · Abacavir Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1dd9bae-73fc-4f4c-aaad-727948216236
GET /v1/drugs/d1dd9bae-73fc-4f4c-aaad-727948216236?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62070450",
  "date_amm": "1999-07-08",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/99/112",
  "substance": "ABACAVIR (SULFATE D')",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about abacavir (sulfate d').

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.